Telsey Advisory Group reaffirmed their outperform rating on shares of Waldencast (NASDAQ:WALD – Free Report) in a research note issued to investors on Wednesday, Benzinga reports. They currently have a $6.00 price objective on the stock.
Separately, DA Davidson upped their price objective on Waldencast from $6.50 to $7.25 and gave the company a buy rating in a research report on Wednesday, September 4th.
Get Our Latest Stock Report on Waldencast
Waldencast Price Performance
Institutional Investors Weigh In On Waldencast
A number of hedge funds have recently modified their holdings of the business. Marshall Wace LLP bought a new position in Waldencast in the 2nd quarter worth $37,000. Catalina Capital Group LLC bought a new position in shares of Waldencast in the first quarter worth about $73,000. Norden Group LLC purchased a new position in shares of Waldencast during the 1st quarter valued at about $92,000. Bleakley Financial Group LLC bought a new position in shares of Waldencast during the 1st quarter valued at approximately $142,000. Finally, Cubist Systematic Strategies LLC purchased a new stake in Waldencast in the 2nd quarter worth approximately $85,000. Institutional investors own 41.97% of the company’s stock.
About Waldencast
Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.
Read More
- Five stocks we like better than Waldencast
- Quiet Period Expirations Explained
- 3 Micro-Caps Set for Major Moves: Balancing Risk and Opportunity
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Autodesk Named a “Top Pick” by Morgan Stanley—Is It Time to Buy?
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- 4 Quirky ETFs With Big Potential for Impressive Gains
Receive News & Ratings for Waldencast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waldencast and related companies with MarketBeat.com's FREE daily email newsletter.